Data / Form D filings / ORF Biologics, Inc.
ORF Biologics, Inc.: Form D filings
ORF Biologics, Inc., a biotechnology company in Tiffin, IA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on July 31, 2026, reports $1.7 million sold of a $2.5 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1110 TALL GRASS DRIVE, Tiffin, IA, 52340
- Phone
- (319) 992-0004
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Iowa
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2048350
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | New notice | $2,500,000 | $1,734,220 | $765,780 | 17 | Jul 23, 2026 | sec.gov |
| Dec 12, 2024 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Michalicek | Director | |
| Anant Kamath | Executive Officer, Director | |
| Jay Kamath | Executive Officer | |
| Sara Ternes | Executive Officer | |
| Nicholas Taiber | Director | |
| Roger A. Baker | Director | |
| John R. Huiskamp | Director |
Every Form D from the week of Jul 27, 2026 · All recent filings in Iowa · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ORF Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.